PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Insera Therapeutics, Inc.

USPTO PatentsView assignee record — 22 granted patents across 8 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D04C (BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE).

Explore the portfolio See the ranking
22
Total patents granted
8
CPC technology areas
16.6
Avg claims per patent
-84%
5-year filing velocity

Portfolio overview

Insera Therapeutics, Inc. has been granted 22 US utility patents between 2015 and 2022, placing Insera Therapeutics, Inc. at rank #13,491 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in D04C (BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE). As a US Corporation, Insera Therapeutics, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 31.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 19 in the 2015–2019 window — a -84% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Insera Therapeutics, Inc.'s 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Insera Therapeutics, Inc. against peers pursuing similar technology classes.

How does Insera compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Insera holds 22 patents — placing it at rank #13,491 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2022

0246810 2015201620172018201920202022 1
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Insera Therapeutics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 22.7%
2016 1 4.5%
2017 3 13.6%
2018 1 4.5%
2019 9 40.9%
2020 2 9.1%
2022 1 4.5%

Which technologies does Insera Therapeutics, Inc. patent most?

Top 8 of 8 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#13,491

Across all tracked assignees

Innovation Score

31.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Insera Therapeutics, Inc. hold?
Insera Therapeutics, Inc. holds 22 US granted patents filed between 2015 and 2022, spanning 8 technology areas.
What is Insera Therapeutics, Inc.'s Innovation Score?
Insera Therapeutics, Inc. has an Innovation Score of 31.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Insera Therapeutics, Inc. focus on?
Insera Therapeutics, Inc.'s top technology area is D04C (BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE) with 16 patents. The company has filed patents in 8 CPC subclasses total.
Is Insera Therapeutics, Inc.'s patent filing rate increasing or decreasing?
Insera Therapeutics, Inc.'s recent filing velocity is -84% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Insera Therapeutics, Inc.'s patents?
Insera Therapeutics, Inc.'s patents average 16.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Insera Therapeutics, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

D04C technology

Insera Therapeutics, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Insera Therapeutics, Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope